This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Search results
From Proteopedia
You searched for Development/2024-09
There is no page with the exact title "Development/2024-09". The search results for "Development/2024-09" are displayed below. You can create a page titled Development/2024-09 (by clicking on the red link).
For more information about searching Proteopedia, see Help.
To exclude pages titled with 4-character PDB codes, use the checkbox "only Human created pages" at the bottom of this page.
Showing below up to 20 results starting with #1.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
No page title matches
Page text matches
- 9bbl (8,593 bytes)
15: ...ibrils adopting the AD fold should facilitate the development of diagnostic and therapeutic compounds that targ... - 9bbm (8,593 bytes)
15: ...ibrils adopting the AD fold should facilitate the development of diagnostic and therapeutic compounds that targ... - User:Anna Leibinger/Sandbox 1 (12,800 bytes)
91: ...l growth and apoptosis, so it plays a role in the development of cancer. In fact, It can act as a potential tum... - 8tpv (4,783 bytes)
16: ...se compounds are excellent candidates for further development as drug leads against infectious diseases as well...
18: Development of Prolinol Containing Inhibitors of Hypoxanthine... - 8tve (3,136 bytes)
12: ...stabilization strategy. Our data will support the development of vaccines and therapeutics against LayV and clo... - 8tvf (3,191 bytes)
12: ...stabilization strategy. Our data will support the development of vaccines and therapeutics against LayV and clo... - 8tvg (3,204 bytes)
12: ...stabilization strategy. Our data will support the development of vaccines and therapeutics against LayV and clo... - 8tvh (3,375 bytes)
14: ...stabilization strategy. Our data will support the development of vaccines and therapeutics against LayV and clo... - 8tpy (4,758 bytes)
16: ...se compounds are excellent candidates for further development as drug leads against infectious diseases as well...
18: Development of Prolinol Containing Inhibitors of Hypoxanthine... - 8ts4 (3,863 bytes)
14: ...se compounds are excellent candidates for further development as drug leads against infectious diseases as well...
16: Development of Prolinol Containing Inhibitors of Hypoxanthine... - 8f9g (3,719 bytes)
12: ...ation and may be an effective tool in HIV vaccine development. - 8f9m (3,811 bytes)
12: ...ation and may be an effective tool in HIV vaccine development. - 9b1r (3,647 bytes)
14: ...unctions, including storing nutrients during seed development. Despite many years of intense studies on VSRs, a... - 8yr7 (4,077 bytes)
13: ...y is crucial in establishing cell polarity during development and tissue homoeostasis. This pathway is found to... - 8tqx (3,458 bytes)
14: ...iary structures in Zika virus stem-loop A for the development of inhibitory small molecules.,Tipo J, Gottipati ... - 8tr1 (3,822 bytes)
14: ...se compounds are excellent candidates for further development as drug leads against infectious diseases as well...
16: Development of Prolinol Containing Inhibitors of Hypoxanthine... - 8tqd (6,339 bytes)
14: ...proteomic platforms have accelerated the clinical development of covalent inhibitors for a wide range of target... - 8tnx (3,657 bytes)
16: ...ms and provide foundations for future therapeutic development against various human diseases. - 8z9b (3,109 bytes)
10: ...t/MTB12_MYCTO MTB12_MYCTO] May play a role in the development of protective immune responses.
13: ...ffer valuable insights for vaccine design and the development of diagnostic tools. - 8ur9 (8,403 bytes)
14: ...ently approved alternate antiviral, molnupiravir. Development and subsequent testing of a capsule formulation f...
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
You may also try
